Company
United StatesPublic company, NASDAQ: INDPINDAPTUS THERAPEUTICS, INC (NASDAQ: INDP), New York, NY – FDA Inspections
Inspection records and compliance data for INDAPTUS THERAPEUTICS, INC in New York, New York. 1 FDA inspection on record, last inspected August 07, 2025. Publicly traded as NASDAQ: INDP.
Company Profile
This profile covers INDAPTUS THERAPEUTICS, INC based in New York, New York, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected August 7, 2025.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 7, 2025 | Not classified | Biologics | 1280333 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
INDAPTUS THERAPEUTICS, INC
Stock ticker
INDP
Exchange
NASDAQ
Share price
$3.15
Market cap
$483.8M
Price as of
November 6, 2026
FEI Number
3023033888
Address
3 Columbus Cir Fl 15, New York, New York 10019, United States
Country
United States
ID: c3be5d97-1d09-4775-94bf-dbc38d1333d6